Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

NCT04469075 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Recurrent Glioblastoma
Skin Toxicity

Interventions

DRUG: Clindamycin Phosphate
DRUG: Triamcinolone Acetonide

Sponsor

Memorial Sloan Kettering Cancer Center